# Aquestive Therapeutics, Inc.

Type: Company (AQST)

Source: GetYourBrief — https://getyourbrief.com/entity/aquestive-therapeutics-inc
Canonical HTML page: https://getyourbrief.com/entity/aquestive-therapeutics-inc

## Recent coverage (3 stories, network-wide)

### Pomerantz Law Firm Issues Litigation Deadlines for TCOM, AQST, and DRVN
2026-03-13 02:09:36 · Sector: finance · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz Law Firm has issued urgent reminders for investors regarding class action lawsuits against Trip.com Group, Aquestive Therapeutics, and Driven Brands Holdings. These legal actions focus on alleged securities violations and material misrepresentations that resulted in significant shareholder losses.
Full story: https://getfinancebrief.com/story/pomerantz-law-firm-investor-alerts-tcom-aqst-drvn

### Aquestive Therapeutics Faces Legal Scrutiny Amid Earnings Miss and Insider Sales
2026-03-13 02:06:17 · Sector: bio · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz Law Firm has issued a formal reminder to Aquestive Therapeutics (AQST) investors regarding an ongoing class action lawsuit following a period of financial underperformance. The litigation coincides with a recent quarterly earnings miss and notable insider selling, creating a challenging regulatory and legal environment for the biotech firm.
Full story: https://getbiobrief.com/story/aquestive-therapeutics-legal-scrutiny-class-action

### Pomerantz Law Firm Issues Class Action Deadlines for TCOM, DRVN, and AQST
2026-03-13 02:02:21 · Sector: legal · Sentiment: Neutral · Impact: 5/10 · Sources: 3

Pomerantz Law Firm has issued urgent reminders to investors regarding upcoming lead plaintiff deadlines in class action lawsuits against Trip.com Group Limited, Driven Brands Holdings Inc., and Aquestive Therapeutics, Inc. These legal actions allege violations of federal securities laws, primarily focusing on misleading statements or omissions that resulted in significant financial losses for shareholders.
Full story: https://getlegalbrief.com/story/pomerantz-law-firm-securities-litigation-alerts-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.